Cargando…
Lethal neonatal mitochondrial phenotype caused by a novel polymerase subunit gamma mutation: A case report
RATIONALE: Polymerase subunit gamma (POLG) is a gene that codes for the catalytic subunit of the mitochondrial DNA polymerase, which is involved in the replication of mitochondrial DNA. Mutations in these genes are associated with a range of clinical syndromes characterized by secondary mtDNA defect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200512/ https://www.ncbi.nlm.nih.gov/pubmed/30290626 http://dx.doi.org/10.1097/MD.0000000000012591 |
Sumario: | RATIONALE: Polymerase subunit gamma (POLG) is a gene that codes for the catalytic subunit of the mitochondrial DNA polymerase, which is involved in the replication of mitochondrial DNA. Mutations in these genes are associated with a range of clinical syndromes characterized by secondary mtDNA defect including mtDNA mutation and mtDNA depletion which may culminate in complete failure of energy production (respiratory changes complex 1 defect) as in this case. PATIENT CONCERNS: We herein report a full term Saudi female neonate born to consanguineous parents, who was noticed immediately after birth to have severe hypotonia, poor respiratory effort, and dysmorphic features. She had 3 siblings who died with same clinical scenario in neonatal period. DIAGNOSES: Molecular genetic testing revealed a novel compound heterozygous mutation of POLG gene c.680G>A (p.Arg227Gin) and c.3098C>T (p.Ala1033Val). INTERVENTIONS: The patient remained in neonatal intensive care unit with multidisciplinary team management and was ventilator dependent until she passed away. OUTCOMES: The detected mutation had led to complete failure of energy production (respiratory changes complex 1 defect) until she died at the age of 5 months. LESSONS: Mitochondrial respiratory chain defect should be considered in patients with severe neonatal hypotonia,encephalopathy, and respiratory failure especially in highly consanguineous population. |
---|